ROP
65
6
OI
50
7
AKAM
62
6
TRV
62
-2
AZO
43
-2
CAG
36
-3
MHK
55
12
VMC
60
-3
WEC
43
-3
CHRW
50
2
LH
50
-5
CHD
48
-5
BEN
48
2
A
46
3
CMI
56
5
MKC
59
-3
LNC
50
11
QRVO
38
5
CVX
40
2
PNW
63
-3
ROP
65
6
OI
50
7
AKAM
62
6
TRV
62
-2
AZO
43
-2
CAG
36
-3
MHK
55
12
VMC
60
-3
WEC
43
-3
CHRW
50
2
LH
50
-5
CHD
48
-5
BEN
48
2
A
46
3
CMI
56
5
MKC
59
-3
LNC
50
11
QRVO
38
5
CVX
40
2
PNW
63
-3
Financhill
Back

Verrica Pharmaceuticals Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
25

VRCA
Verrica Pharmaceuticals

Last Price:
1.94
Seasonality Move:
-10.89%
Sell
35

BMRN
Biomarin Pharmaceutical

Last Price:
71.43
Seasonality Move:
5.7%
Sell
25
Verrica Pharmaceuticals (VRCA) is a Sell

Is Verrica Pharmaceuticals a Buy, Sell or Hold?

  • The current Verrica Pharmaceuticals [VRCA] share price is $1.94. The Score for VRCA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Biomarin Pharmaceutical (BMRN) is a Sell

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $71.43. The Score for BMRN is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • BMRN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VRCA Stock Price Chart

What is Verrica Pharmaceuticals's stock price today?

  • The Verrica Pharmaceuticals share price today is $1.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing slight buying pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $71.43
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight buying pressure.

VRCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.67 Sell
Relative Strength Index (14 RSI): 26.9 Sell
Chaikin Money Flow: 25376 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.91 - 2.71) Sell
Bollinger Bands (100): (3.74 - 8.76) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.05 Sell
Relative Strength Index (14 RSI): 23.59 Sell
Chaikin Money Flow: 529461 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (78.7 - 93.16) Sell
Bollinger Bands (100): (78.33 - 88.33) Sell

VRCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.91 Buy
20-day SMA: 2.17 Sell
50-day SMA: 4.45 Sell
200-day SMA: 5.98 Sell
8-day EMA: 1.94 Buy
20-day EMA: 2.39 Sell
50-day EMA: 3.88 Sell
200-day EMA: 5.53 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 77.73 Sell
20-day SMA: 84.51 Sell
50-day SMA: 85.71 Sell
200-day SMA: 86.92 Sell
8-day EMA: 76.32 Sell
20-day EMA: 81.77 Sell
50-day EMA: 84.33 Sell
200-day EMA: 86.01 Sell

Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.68 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.29 per share, an increase this year of $1.19 per share, and an increase next year of $1.04 per share.

Verrica Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):